A minimal common outcome measure set for COVID-19 clinical researchJohn C. Marshall, Halima Salisu-Kabara, Lennie Derde et al.|The Lancet Infectious Diseases|2020Cited by 1.8k
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary reportChristopher W. Seymour, Anthony Gordon, Paul Mouncey et al.|medRxiv|2021Cited by 137
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal KenyaAnna C. Seale, James A. Berkley, Angela Koech et al.|Nature Microbiology|2016Cited by 114
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Anthony Gordon, Lennie Derde et al.|Intensive Care Medicine|2021Cited by 100
The<i>Staphylococcus aureus</i>Network Adaptive Platform Trial Protocol: New Tools for an Old FoeSteven Y. C. Tong, Adrian Dunlop, Jocelyn Mora et al.|Clinical Infectious Diseases|2022Cited by 98